ID   COR-L103
AC   CVCL_D744
SY   COR L103; Cor L103; CORL103
DR   ECACC; 96020735
DR   Wikidata; Q54814268
RX   PubMed=1327513;
RX   PubMed=3034934;
RX   PubMed=8383976;
CC   Population: Caucasian.
CC   Discontinued: ECACC; 96020735; probable.
DI   NCIt; C4917; Lung small cell carcinoma
DI   ORDO; Orphanet_70573; Small cell lung cancer
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_2409 ! COR-L24
SX   Male
AG   71Y
CA   Cancer cell line
DT   Created: 22-10-12; Last updated: 29-06-23; Version: 13
//
RX   PubMed=1327513;
RA   Twentyman P.R., Wright K.A., Mistry P., Kelland L.R., Murrer B.A.;
RT   "Sensitivity to novel platinum compounds of panels of human lung
RT   cancer cell lines with acquired and inherent resistance to
RT   cisplatin.";
RL   Cancer Res. 52:5674-5680(1992).
//
RX   PubMed=3034934; DOI=10.1002/jcb.240330405;
RA   Ibson J.M., Waters J.J., Twentyman P.R., Bleehen N.M., Rabbitts P.H.;
RT   "Oncogene amplification and chromosomal abnormalities in small cell
RT   lung cancer.";
RL   J. Cell. Biochem. 33:267-288(1987).
//
RX   PubMed=8383976; DOI=10.1677/jme.0.0100025;
RA   Farrell W.E., Stewart M.F., Clark A.J.L., Crosby S.R., Davis J.R.E.,
RA   White A.;
RT   "Glucocorticoid inhibition of ACTH peptides: small cell lung cancer
RT   cell lines are more resistant than pituitary corticotroph adenoma
RT   cells.";
RL   J. Mol. Endocrinol. 10:25-32(1993).
//